News | CT Angiography (CTA) | July 11, 2019

Mednax CMO Ricardo Cury, M.D., will discuss how partnership with Baptist Health South Florida results in $1,000 savings per-episode, decreased length of stay, reduced effective radiation dose

Mednax National Cardiac Centers of Excellence Program Highlighted at SCCT 2019

July 11, 2019 — Mednax Inc. and Mednax Radiology Solutions announced that Chief Medical Officer Ricardo C. Cury, M.D., FSCCT, will present at the 14th Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography (SCCT), July 11-14 in Baltimore. His session is titled “Building a National Centers of Excellence in Coronary Computed Tomography Angiography (CCTA) to Support Implementation in Clinical Practice.”

“Many emergency departments lack standardized CCTA care processes or have outdated ones. This results in significant patient care variations, which ultimately leads to longer lengths of stay that decrease patient satisfaction and increase costs,” said Cury. “The Mednax Radiology Solutions Cardiac Centers of Excellence Program and Baptist Health South Florida in Miami led the way to develop new CCTA protocols, subspecialist interpretation coverage, and training programs for emergency department physicians, hospitalists, cardiologists, nursing staff and technologists in appropriate CCTA utilization. As a result, Baptist Health realized dramatic gains in efficiency, cost savings and patient satisfaction, including a decrease in the average per-case episode cost by more than $1,000.”

In addition to the decrease in episode cost, Baptist Health’s new CCTA protocols lead to a:

  • Fifty (50) percent decrease in length of stay;

  • Low rate for major adverse cardiac events (MACE) with a negative predictive value of 99.8 percent; and

  • Significant (58.3 percent) decrease in effective radiation dose using iterative reconstructions and tailored protocols. 

CCTA is a contrast-enhanced radiographic assessment of the coronary arteries. It is a non-invasive alternative that can show narrowed or blocked blood vessels. Although CCTA has been endorsed by several guidelines from the American College of Cardiology/American Heart Association, CCTA has been slow to be adopted for low- to intermediate-risk chest pain patients. Through its Centers of Excellence, Mednax works to leverage such best-practice programs across its national network and expand services and technology nationwide to provide better and faster care for patients.

Watch the VIDEO: Trends In Cardiac CT Imaging at SCCT 2015, an interview with Cury

For more information: www.mednax.com/radiology


Related Content

News | Lung Imaging

April, 15, 2025 — Optellum has entered an agreement with Bristol Myers Squibb to leverage AI in early diagnosis and ...

Time April 17, 2025
arrow
News | Artificial Intelligence

April 16, 2025 — An artificial intelligence (AI) program trained to review images from a common medical test can detect ...

Time April 16, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | SPECT Imaging

Feb. 5, 2025 — Serac Healthcare Ltd., a clinical radiopharmaceutical company developing an innovative molecular imaging ...

Time February 05, 2025
arrow
News | Computed Tomography (CT)

Dec. 3, 2024 — During RSNA '24, GE HealthCare announced the 510(k) submission to the U.S. Food and Drug Administration ...

Time December 18, 2024
arrow
News | SPECT Imaging

Dec. 2, 2024 — GE HealthCare has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing ...

Time December 05, 2024
arrow
News | Computed Tomography (CT)

At the annual AHRA (American Healthcare Radiology Administrators) conference in Orlando, Florida, Bayer announced an ...

Time August 09, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
Subscribe Now